Comparative analysis of telomere length in peripheral blood of breast cancer BRCA1 mutation carriers and non-carriers
LTL shortening is associated with BRCA1 mutations, regardless of cancer status. Further validation studies are needed.
Authors
- Anusha Uttarilli (ORCID: https://orcid.org/0000-0001-6243-6510)
- Pavel Vodička (ORCID: https://orcid.org/0000-0003-2376-1243)
- Michal Kroupa (ORCID: https://orcid.org/0000-0001-9112-7047)
- Petr Hanák (ORCID: https://orcid.org/0000-0002-2156-592X)
- Kristýna Tomášová (ORCID: https://orcid.org/0000-0002-8080-6666)
- Katerina Saskova
- Kateřina Balounová
- J. Lubiński
- Ludmila Vodickova
- Kari Hemminki
Institutions
- German Cancer Research Center (DE)
- Czech Academy of Sciences (CZ)
- Charles University (CZ)
- Heidelberg University (DE)
- Czech Academy of Sciences, Institute of Experimental Medicine (CZ)
- Pomeranian Medical University (PL)
Publication Details
- Journal
- Discover Oncology
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1007/s12672-025-04007-8
- Primary Topic
- Telomeres, Telomerase, and Senescence
- Type
- article
- Field-Weighted Citation Impact
- 0.00